ACET
Price
$0.85
Change
-$0.15 (-15.00%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
71.02M
28 days until earnings call
ORGO
Price
$4.15
Change
-$0.05 (-1.19%)
Updated
Oct 7, 04:59 PM (EDT)
Capitalization
525.19M
29 days until earnings call
Interact to see
Advertisement

ACET vs ORGO

Header iconACET vs ORGO Comparison
Open Charts ACET vs ORGOBanner chart's image
Adicet Bio
Price$0.85
Change-$0.15 (-15.00%)
Volume$169.62K
Capitalization71.02M
Organogenesis Holdings
Price$4.15
Change-$0.05 (-1.19%)
Volume$23.96K
Capitalization525.19M
ACET vs ORGO Comparison Chart in %
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ORGO commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and ORGO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ACET: $0.85 vs. ORGO: $4.14)
Brand notoriety: ACET and ORGO are both not notable
ACET represents the Biotechnology, while ORGO is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACET: 2334% vs. ORGO: 57%
Market capitalization -- ACET: $71.02M vs. ORGO: $525.19M
ACET [@Biotechnology] is valued at $71.02M. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $525.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 4 bearish.
  • ORGO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ORGO.

Price Growth

ACET (@Biotechnology) experienced а +5.29% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.29%. For the same industry, the average monthly price growth was +5.68%, and the average quarterly price growth was +62.35%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

ORGO is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+1.29% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORGO($525M) has a higher market cap than ACET($71M). ORGO YTD gains are higher at: 29.375 vs. ACET (-11.320). ORGO has higher annual earnings (EBITDA): 3.19M vs. ACET (-112.08M). ACET has more cash in the bank: 125M vs. ORGO (73.1M). ACET has less debt than ORGO: ACET (15.4M) vs ORGO (40.8M). ORGO has higher revenues than ACET: ORGO (429M) vs ACET (0).
ACETORGOACET / ORGO
Capitalization71M525M14%
EBITDA-112.08M3.19M-3,513%
Gain YTD-11.32029.375-39%
P/E RatioN/A63.75-
Revenue0429M-
Total Cash125M73.1M171%
Total Debt15.4M40.8M38%
FUNDAMENTALS RATINGS
ACET vs ORGO: Fundamental Ratings
ACET
ORGO
OUTLOOK RATING
1..100
169
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
3962
P/E GROWTH RATING
1..100
189
SEASONALITY SCORE
1..100
350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (43) in the Medical Distributors industry is in the same range as ORGO (74) in the Financial Conglomerates industry. This means that ACET’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's Profit vs Risk Rating (99) in the Financial Conglomerates industry is in the same range as ACET (100) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

ORGO's SMR Rating (94) in the Financial Conglomerates industry is in the same range as ACET (98) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

ACET's Price Growth Rating (39) in the Medical Distributors industry is in the same range as ORGO (62) in the Financial Conglomerates industry. This means that ACET’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (9) in the Financial Conglomerates industry is in the same range as ACET (18) in the Medical Distributors industry. This means that ORGO’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETORGO
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 8 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 14 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMTFF0.05N/A
+2.11%
AmeriTrust Financial Technologies Inc.
METOF0.11N/A
+0.85%
Meteoric Resorces NL
ETCIA0.01N/A
N/A
Electronic Tele-Communications, Inc.
APMSF30.50N/A
N/A
Aperam S.A.
SNPTF11.30-0.32
-2.80%
Sunny Optical Technology (Group) Co Ltd